We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Hodgkin Lymphoma

Advances in Diagnosis and Treatment of Hodgkin Lymphoma

While Hodgkin lymphoma is a less common form of lymphoma cancer, accounting for only about 1 percent of all cancers in the U.S., our lymphoma specialists at University Hospitals Seidman Cancer Center are focused only on diseases of the lymphatic system. Through advances in diagnosis and treatments, including access to lymphoma-specific clinical trials, we are improving chances for recovery for our patients every day.

Because our team of physician-scientists are focused only on lymphoma cancers, one clinical team is fully responsible for each patient’s care, whether they are in the hospital or at home. Integrated treatment plans may include chemotherapy, radiation therapy or stem cell transplant. In addition, UH Seidman Cancer Center offers a range of support services, delivering compassionate care by better understanding patient and family needs.

Access to Clinical Trials at UH Seidman Cancer Center

Our physician-scientists at UH Seidman Cancer Center are experts in the diagnosis and treatment of cancers of the lymphatic system. With the progression of these cancers that affect the immune system, the patient’s ability to fight infection may be compromised, so it is critical to seek care from cancer specialists who are focused only on that type of cancer. Our team works together as part of the hematologic malignancies tumor board to review every case and develop an individualized care plan.

Offering Hodgkin lymphoma-specific clinical trials, our team can use therapies that are safer and more tolerable for Hodgkin lymphoma patients. With access to these targeted clinical trials, our patients have the opportunity to improve their potential for cure, while also strengthening hope for the future of cancer care.